2024 Q3 Form 10-K Financial Statement

#000182912624005453 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q4 2023
Revenue $128.0K $1.506M $4.859M
YoY Change -89.87% -23.05% -38.0%
Cost Of Revenue $336.0K $12.44M $18.29M
YoY Change -86.32% 406.8% 113.11%
Gross Profit -$208.0K -$10.94M -$13.43M
YoY Change -82.55% 2095.98% 1704.84%
Gross Profit Margin -162.5% -726.16% -276.35%
Selling, General & Admin $3.135M $6.732M $32.47M
YoY Change -64.84% -27.28% -9.6%
% of Gross Profit
Research & Development $411.0K $3.957M $12.11M
YoY Change -80.71% 60.98% 23.64%
% of Gross Profit
Depreciation & Amortization $200.0K $116.0K $3.005M
YoY Change -77.78% -82.18% 101.27%
% of Gross Profit
Operating Expenses $3.546M $10.69M $44.58M
YoY Change -67.9% -8.77% -2.47%
Operating Profit -$7.927M -$25.70M -$70.34M
YoY Change -32.0% -48.69% -17.66%
Interest Expense -$53.00K $171.0K
YoY Change -352.38% -538.46%
% of Operating Profit
Other Income/Expense, Net -$2.000K -$19.00K -$902.0K
YoY Change -98.37% -575.0% 317.59%
Pretax Income -$9.615M -$25.73M -$70.68M
YoY Change -19.38% -46.31% -7.38%
Income Tax $0.00 -$1.000K $719.0K
% Of Pretax Income
Net Earnings -$18.52M -$25.73M -$71.40M
YoY Change 56.36% -45.97% -3.95%
Net Earnings / Revenue -14470.31% -1708.63% -1469.38%
Basic Earnings Per Share -$7.03 -$12.04 -$37.24
Diluted Earnings Per Share -$7.03 -$12.04 -$37.24
COMMON SHARES
Basic Shares Outstanding 2.637M shares 62.53M shares 1.917M shares
Diluted Shares Outstanding 2.637M shares 2.137M shares 1.917M shares

Balance Sheet

Concept 2024 Q3 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.562M $3.562M
YoY Change -89.16% -89.16%
Cash & Equivalents $192.0K $3.562M $3.562M
Short-Term Investments
Other Short-Term Assets $313.0K $1.105M $1.339M
YoY Change -86.27% -51.79% 65.51%
Inventory $97.00K $2.707M $2.707M
Prepaid Expenses $548.0K $1.149M
Receivables $274.0K $191.0K $212.0K
Other Receivables $1.015M $1.015M
Total Short-Term Assets $1.424M $8.835M $8.835M
YoY Change -93.95% -82.15% -82.15%
LONG-TERM ASSETS
Property, Plant & Equipment $5.310M $21.55M $24.77M
YoY Change -78.11% 20.13% 12.6%
Goodwill
YoY Change
Intangibles $77.00K $79.00K
YoY Change -95.7% -98.7%
Long-Term Investments
YoY Change
Other Assets $239.0K $308.0K $1.058M
YoY Change -76.64% -94.84% -83.18%
Total Long-Term Assets $5.905M $25.90M $25.90M
YoY Change -81.48% -35.39% -35.39%
TOTAL ASSETS
Total Short-Term Assets $1.424M $8.835M $8.835M
Total Long-Term Assets $5.905M $25.90M $25.90M
Total Assets $7.329M $34.74M $34.74M
YoY Change -86.77% -61.23% -61.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.42M $5.087M $5.087M
YoY Change 167.69% 8.7% 46.18%
Accrued Expenses $563.0K $831.0K $3.326M
YoY Change -50.57% -45.4% -18.94%
Deferred Revenue $1.230M $2.015M
YoY Change 72.75% 97.74%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.14M $11.91M $11.91M
YoY Change 96.21% -12.83% -12.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000K $684.0K $9.376M
YoY Change -99.86% -19.72% -20.37%
Total Long-Term Liabilities $259.0K $9.376M $9.376M
YoY Change -97.41% -20.37% -20.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.14M $11.91M $11.91M
Total Long-Term Liabilities $259.0K $9.376M $9.376M
Total Liabilities $25.40M $21.29M $21.29M
YoY Change 11.34% -16.32% -16.32%
SHAREHOLDERS EQUITY
Retained Earnings -$218.3M -$179.2M
YoY Change 42.29% 66.25%
Common Stock $0.00 $8.000K
YoY Change -100.0% 60.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$18.07M $13.45M $13.45M
YoY Change
Total Liabilities & Shareholders Equity $7.329M $34.74M $34.74M
YoY Change -86.77% -61.23% -61.23%

Cashflow Statement

Concept 2024 Q3 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$18.52M -$25.73M -$71.40M
YoY Change 56.36% -45.97% -3.95%
Depreciation, Depletion And Amortization $200.0K $116.0K $3.005M
YoY Change -77.78% -82.18% 101.27%
Cash From Operating Activities -$5.777M -$32.12M
YoY Change -14190.24% -0.03%
INVESTING ACTIVITIES
Capital Expenditures $145.0K $3.371M
YoY Change -98.18% -71.05%
Acquisitions $1.864M
YoY Change
Other Investing Activities $256.0K -$2.863M
YoY Change -110.02% -0.35%
Cash From Investing Activities $111.0K -$6.234M
YoY Change -101.05% -57.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.571M $9.059M
YoY Change 357000.0% -22747.5%
NET CHANGE
Cash From Operating Activities -5.777M -$32.12M
Cash From Investing Activities 111.0K -$6.234M
Cash From Financing Activities 3.571M $9.059M
Net Change In Cash -2.095M -$29.29M
YoY Change -80.03% -37.26%
FREE CASH FLOW
Cash From Operating Activities -$5.777M -$32.12M
Capital Expenditures $145.0K $3.371M
Free Cash Flow -$5.922M -$35.49M
YoY Change -25.39% -18.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001744494
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2023Q4 us-gaap Goodwill
Goodwill
usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
usd
CY2023 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
usd
CY2023 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 adn Provision For Inventories
ProvisionForInventories
usd
CY2023 adn Proceeds For Tenant Improvement Incentive From Landlord
ProceedsForTenantImprovementIncentiveFromLandlord
usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2023 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
usd
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2023 us-gaap Repayments Of Debt
RepaymentsOfDebt
usd
CY2023 adn Assets Acquired Under Operating Leases
AssetsAcquiredUnderOperatingLeases
usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2022 adn Utilized Provisions During Year
UtilizedProvisionsDuringYear
usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
usd
CY2023Q4 adn Accrued Interest Income
AccruedInterestIncome
usd
CY2022Q4 adn Accrued Sublease Income
AccruedSubleaseIncome
usd
CY2023Q4 us-gaap Goodwill
Goodwill
usd
CY2022Q4 adn Less Cumulative Impairment
LessCumulativeImpairment
usd
CY2023Q4 adn Accrued Construction Fees Current
AccruedConstructionFeesCurrent
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
usd
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
usd
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
usd
CY2023Q4 adn Contractual Obligation Quantity Pieces Year One
ContractualObligationQuantityPiecesYearOne
electrodes
CY2023Q4 adn Contractual Obligation Quantity Pieces Year Two
ContractualObligationQuantityPiecesYearTwo
electrodes
CY2023Q4 adn Contractual Obligation Quantity Pieces Year Two
ContractualObligationQuantityPiecesYearTwo
CY2023Q4 adn Contractual Obligation Quantity Pieces
ContractualObligationQuantityPieces
electrodes
CY2023Q4 us-gaap Goodwill
Goodwill
usd
CY2023Q4 adn Available For Sale Financial Asset
AvailableForSaleFinancialAsset
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
usd
CY2023Q3 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
usd
CY2023Q1 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2022Q3 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
usd
CY2022Q2 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
usd
CY2022Q1 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
usd
CY2022Q3 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
usd
CY2022Q2 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
usd
CY2022Q1 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
usd
CY2022Q3 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
usd
CY2022Q2 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
usd
CY2022Q1 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Advent Technologies Holdings, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity File Number
EntityFileNumber
001-38742
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0982969
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
5637 La Ribera St.
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Livermore
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94550
CY2023 dei City Area Code
CityAreaCode
(925)
CY2023 dei Local Phone Number
LocalPhoneNumber
455-9400
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
27300000 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2636508 shares
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
1457
CY2023 dei Auditor Name
AuditorName
Ernst & Young (Hellas) Certified Auditors Accountants
CY2023 dei Auditor Location
AuditorLocation
Athens, Greece
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3562000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32869000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
191000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
979000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
21000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
52000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2707000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
12620000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2254000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2980000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
8835000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
49500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5742000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6062000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21549000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17938000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3216000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4055000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
308000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5221000 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
320000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
25902000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
40088000 usd
CY2023Q4 us-gaap Assets
Assets
34737000 usd
CY2022Q4 us-gaap Assets
Assets
89588000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5087000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4680000 usd
CY2023Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
530000 usd
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
801000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2015000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1019000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1916000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4703000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2186000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2280000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
179000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
183000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11913000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13666000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
59000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
998000 usd
CY2023Q4 adn Longterm Operating Lease Liabilities
LongtermOperatingLeaseLiabilities
8230000 usd
CY2022Q4 adn Longterm Operating Lease Liabilities
LongtermOperatingLeaseLiabilities
9802000 usd
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
83000 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
72000 usd
CY2023Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
320000 usd
CY2022Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
50000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
684000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
852000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9376000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
11774000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
21289000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
25440000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1723924 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1723924 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
194933000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
174509000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2334000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2604000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179159000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-107762000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
13448000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
64148000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34737000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89588000 usd
CY2023 us-gaap Revenues
Revenues
4859000 usd
CY2022 us-gaap Revenues
Revenues
7837000 usd
CY2023 adn Income From Grant
IncomeFromGrant
2504000 usd
CY2022 adn Income From Grant
IncomeFromGrant
1460000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12112000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9796000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32468000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35915000 usd
CY2023 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
543000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
642000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2764000 usd
CY2022 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
1116000 usd
CY2022 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
2370000 usd
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
13468000 usd
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
38922000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-394000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
74000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
52000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
97000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-91000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-902000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-216000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70678000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76307000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
719000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1970000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71397000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74337000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-37.24
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-43.28
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1917179 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1717623 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-37.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-43.28
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1917179 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1717623 shares
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
255000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1370000 usd
CY2023 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
15000 usd
CY2022 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
39000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
270000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1331000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71127000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75668000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
130201000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9615000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74337000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1331000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
64148000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9881000 usd
CY2023 adn Reclassification Of Private Warrants
ReclassificationOfPrivateWarrants
545000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71397000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
270000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71397000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74337000 usd
CY2023 us-gaap Depreciation
Depreciation
3005000 usd
CY2022 us-gaap Depreciation
Depreciation
1493000 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
642000 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2764000 usd
CY2023 adn Credit Loss Allowance
CreditLossAllowance
-1270000 usd
CY2022 adn Credit Loss Allowance
CreditLossAllowance
-1116000 usd
CY2022 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
2370000 usd
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
13468000 usd
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
38922000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-394000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9375000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
9881000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
10414000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
719000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1970000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-3000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-232000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
966000 usd
CY2023 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
23000 usd
CY2022 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
27000 usd
CY2023 adn Provision For Inventories
ProvisionForInventories
11918000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-671000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1830000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
9000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-620000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1827000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5932000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1963000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-5729000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
194000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5434000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-46000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-23000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
649000 usd
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1214000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-247000 usd
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1503000 usd
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-5661000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-9000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-13000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-185000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-46000 usd
CY2022 adn Proceeds For Tenant Improvement Incentive From Landlord
ProceedsForTenantImprovementIncentiveFromLandlord
7958000 usd
CY2023 adn Increase Decrease In Operating Lease Asset And Liabilities
IncreaseDecreaseInOperatingLeaseAssetAndLiabilities
-828000 usd
CY2022 adn Increase Decrease In Operating Lease Asset And Liabilities
IncreaseDecreaseInOperatingLeaseAssetAndLiabilities
78000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32115000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32125000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
256000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2023 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
3371000 usd
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
11527000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
117000 usd
CY2023 adn Payments To Acquire Fixed Assets
PaymentsToAcquireFixedAssets
1255000 usd
CY2022 adn Payments To Acquire Fixed Assets
PaymentsToAcquireFixedAssets
2557000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1864000 usd
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
316000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6234000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14517000 usd
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9059000 usd
CY2022 us-gaap Repayments Of Debt
RepaymentsOfDebt
40000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9059000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29290000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46682000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
537000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33619000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79764000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4412000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33619000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
41000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
15000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-82000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13000 usd
CY2022 adn Assets Acquired Under Operating Leases
AssetsAcquiredUnderOperatingLeases
1594000 usd
CY2023 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_807_eus-gaap--BasisOfAccounting_zW9mpjwtZaai" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1. <span id="xdx_829_z8eCNeYJiwHk">Basis of presentation</span>:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Overview</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advent Technologies Holdings, Inc. and its subsidiaries (collectively referred to as “Advent” or the “Company”) is an advanced materials and technology development company operating in the fuel cell and hydrogen technology space. Advent develops, manufactures and assembles the critical components that determine the performance of hydrogen fuel cells and other energy systems. To date, Advent’s principal operations have been to develop and manufacture Membrane Electrode Assembly (MEA), and fuel cell stacks and complete fuel cell systems for a range of customers in the stationary power, portable power, automotive, aviation, energy storage and sensor markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Advent has its headquarters in Livermore, California, and the Company has MEA fabrication and system production facilities in Livermore, California and Patras, Greece. Previously, the Company’s headquarters were located in Boston, Massachusetts, which included a research and development and manufacturing facility. During 2023, the Company decided to consolidate certain of its German operations with its operations in Greece. During 2024, the Company closed its facilities in Boston, MA, and no longer maintains its facilities in Denmark and the Philippines due to the bankruptcy of Advent Technologies A/S.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 4, 2021 (“Closing Date”), AMCI Acquisition Corp. (“AMCI”), consummated the previously announced business combination (the “Business Combination”) pursuant to that certain merger agreement (the “Agreement and Plan of Merger”), dated October 12, 2020, by and among AMCI, AMCI Merger Sub Corp., a Delaware corporation and newly formed wholly-owned subsidiary of AMCI (“Merger Sub”), AMCI Sponsor LLC (the “Sponsor”), solely in the capacity as the representative from and after the effective time of the Business Combination for the stockholders of AMCI, Advent Technologies, Inc., a Delaware corporation (“Legacy Advent”), and Vassilios Gregoriou, solely in his capacity as the representative from and after the effective time for the Legacy Advent stockholders (the “Seller Representative”), as amended by Amendment No. 1 and Amendment No. 2 to the Agreement and Plan of Merger, dated as of October 19, 2020 and December 31, 2020, respectively, by and among AMCI, Merger Sub, Sponsor, Legacy Advent, and Seller Representative. In connection with the closing of the Business Combination (the “Closing”), AMCI acquired <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_c20210204__us-gaap--BusinessAcquisitionAxis__custom--AMCIAcquisitionCorpMember_pdd" title="Acquired percentage">100%</span> of the stock of Legacy Advent (as it existed immediately prior to the Closing) and its subsidiaries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the Closing Date, and in connection with the closing of the Business Combination, AMCI changed its name to Advent Technologies Holdings, Inc. (the “Company” or “Advent”). Legacy Advent was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification (“ASC”) 805. This determination was primarily based on Legacy Advent’s stockholders prior to the Business Combination having a majority of the voting interests in the combined company, Legacy Advent’s operations comprising the ongoing operations of the combined company, Legacy Advent’s board of directors comprising a majority of the board of directors of the combined company, and Legacy Advent’s senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Advent issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI are stated at historical cost, with no goodwill or other intangible assets recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">While AMCI was the legal acquirer in the Business Combination, because Legacy Advent was deemed the accounting acquirer, the historical financial statements of Legacy Advent became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the consolidated financial statements included in this report reflect (i) the historical operating results of Legacy Advent prior to the Business Combination; (ii) the results of the Company (combined results of AMCI and Legacy Advent) following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Advent at their historical cost; and (iv) Company’s equity structure for all periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20210204__us-gaap--BusinessAcquisitionAxis__custom--AMCIAcquisitionCorpMember_pdd" title="Common stock, par value (in dollars per share)">0.0001</span> par value per share, issued to Legacy Advent’s stockholders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Advent Preferred Stock (“Preferred Series A” and “Preferred Series Seed”) and Legacy Advent common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement. Activity within the statement of changes in stockholders’ equity / (deficit) for the issuances of Legacy Advent’s Preferred Stock, were also retroactively converted to Legacy Advent common stock (Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 18, 2021, Advent Technologies, Inc. entered into a Membership Interest Purchase Agreement with Bren-Tronics, Inc. (“Bren-Tronics”) and UltraCell, LLC (“UltraCell”), a Delaware limited liability company and a direct wholly owned subsidiary of Bren-Tronics (the “UltraCell Purchase Agreement”). See Note 3 “Business Combination” for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">UltraCell LLC was renamed to Advent Technologies LLC following its acquisition by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 25, 2021, the Company entered into a Share Purchase Agreement (the “Purchase Agreement”), with F.E.R. fischer Edelstahlrohre GmbH, a limited liability company incorporated under the Laws of Germany (the “Seller”) to acquire all of the issued and outstanding equity interests in SerEnergy A/S, a Danish stock corporation and a wholly-owned subsidiary of the Seller (“SerEnergy”) and fischer eco solutions GmbH, a German limited liability company and a wholly-owned subsidiary of the Seller (“FES”) together with certain outstanding shareholder loan receivables. See Note 3 “Business Combination” for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">SerEnergy and FES were renamed to Advent Technologies A/S and Advent Technologies GmbH, respectively, following their acquisition by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements of the Company have been prepared to reflect the consolidation of the companies listed below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--SubsidiariesInConsolidationTableTextBlock_pn3n3_zZqrlNtvdjel" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of presentation (Details)"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_z0N6PMPUquLb" style="display: none">Schedule of subsidiaries in consolidation</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership Interest</b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="4" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statements of Operations</b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company Name</b></span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indirect</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember_zOq3ZOeEvB26" title="Company Name">Advent Technologies, Inc.</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember" style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USA</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zmsIOAUfcwz6" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_z2917bZ2YKvd" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0624">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesIncMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember_zXNsiP8x89bb" title="Company Name">Advent Technologies S.A.</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember" style="font-family: Times New Roman, Times, Serif; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greece</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zgUBUXqnjRok" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0634">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zgLI8ECCxKqj" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesSAMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember_zoL6EDurqZO7" title="Company Name">Advent Technologies LLC</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember" style="font-family: Times New Roman, Times, Serif; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USA</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zMqfsqboEota" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0646">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_znncaiIKTYag" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesLLCMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember_zGqiaDsrw0x2" title="Company Name">Advent Technologies GmbH</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember" style="font-family: Times New Roman, Times, Serif; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Germany</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zzKLxgeST7Wd" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zw9GOXO3ULDj" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesGmbHMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember_zRJecAfo3o35" title="Company Name">Advent Technologies A/S</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember" style="font-family: Times New Roman, Times, Serif; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denmark</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember__srt--OwnershipAxis__custom--DirectOwnershipMember_z9Um7kNwV58i" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zxRsDrNgALee" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0672">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventTechnologiesASMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--NameOfSubsidiary_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember_zckCizQY1LTg" title="Company Name">Advent Green Energy Philippines, Inc</span></span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--SubsidiaryPlaceOfIncorporation_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember" style="font-family: Times New Roman, Times, Serif; text-align: center" title="Country of Incorporation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philippines</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember__srt--OwnershipAxis__custom--DirectOwnershipMember_zv1EGZn5KC66" title="Ownership Interest"><span style="-sec-ix-hidden: xdx2ixbrl0682">-</span></span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--OwnershipPercentageInSubsdaries_iI_pid_dp_c20231231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember__srt--OwnershipAxis__custom--IndirectOwnershipMember_zq8Ex9MWZtF9" title="Ownership Interest">100</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--StatementsOfOperationsDate_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--StatementsOfOperationsDate_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--AdventGreenEnergyPhilippinesIncMember" title="Statements of Operations date">01/01 – 12/31</span></span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Going Concern</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company considers that the going concern basis is appropriate for the preparation of its consolidated financial statements, as it is pursuing additional fund raising as disclosed below and has no intentions to proceed with liquidation. The going concern basis of presentation assumes that the Company will continue in operation one year from the date these consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. As such, the accompanying audited consolidated financial statements do not include any adjustments relating to the recoverability and classification of assets and their carrying amounts, or the amount and classification of liabilities that may result should the Company be unable to continue as a going concern. Following the significant non adjusting subsequent events of Advent Technologies A/S bankruptcy and the termination of the Hood Park lease agreement, the Company presents a Proforma Consolidated Balance Sheet as at December 31, 2023 in the Note 24 to the consolidated financial statements to reflect the impact of those events.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date that the consolidated financial statements are issued. The Company’s ability to meet its liquidity needs will largely depend on its ability to raise capital in the very short term and generate cash in the future. During the year ended December 31, 2023, the Company used $32.1 <span id="xdx_90E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_pn3n3_c20230101__20231231_zuuaVkOsPdod" style="display: none" title="Net cash used in operating activities">(32,115)</span> million of cash in operating activities, and the Company’s ability to raise and generate adequate capital and cash in the future is subject to general economic, financial, competitive, legislative, regulatory, and other factors that are beyond the Company’s control. Furthermore, the Company has suffered recurring operating losses and has a negative net working capital position of $<span id="xdx_90A_ecustom--NegativeNetWorkingCapital_iI_pn3n3_dm_c20231231_zXntCxxB6zOh" title="Negative net working capital">3.1</span> million as of December 31, 2023. In addition, as of the issuance date of these consolidated financial statements the Company is overdue in a number of its obligations which could give the right to creditors at any time from the issuance date of these consolidated financial statements to raise legal action against the Company which in turn could potentially lead to liquidation action against the Company and/or its subsidiaries. The transition to profitability and positive cash flow is highly dependent upon the successful development, approval, and commercialization of the Company’s products and the achievement of a revenue level adequate to support its cost structure and the Company can give no assurances that this will occur. Based on the Company’s current operating plan, the Company believes that its cash and cash equivalents as of December 31, 2023, of $<span id="xdx_904_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_dm_c20231231__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_z1iXXnfP9Me7" title="Cash and cash equivalents">3.6</span> million and $<span id="xdx_907_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn3n3_dm_c20240812__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashEquivalentsMember_z7PYX0QIB8A3" title="Cash and cash equivalents">0.1</span> million as of August 12, 2024, are not sufficient to fund operations and capital expenditures for the twelve months following the filing of this Annual Report on Form 10-K, and the Company will need to obtain additional funding in the very near term, otherwise the Company may immediately substantially curtail or terminate its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performed a cash flow projection on a monthly basis for the twelve-month period following the issuance of the consolidated financial statements. With regards to the cash flow projections, the projected inflows from revenues and grants will be insufficient to cover the projected outflows, as such, the Company will continue to have a negative net working capital position and a delay in the projected timing of the short term financing and inflows and/or an immediate demand by creditors of repayment of the long outstanding payables may result in the Company being insolvent and short of cash at any specific time over the coming weeks and over the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The highlights of the projections are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company projects cash inflows from contracted revenues and grants for which it has already signed agreements with third parties and estimates projected outflows assuming the effective implementation of the Company’s plans to reduce monthly expenditures gradually during 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cash flow projections do not include any cash inflows or outflows from Advent Technologies A/S which was declared bankrupt by the court in Aalborg, Denmark on July 25, 2024, and its wholly owned subsidiary Green Energy Philippines, Inc. The Company did not include any outflows relating to Advent Technologies A/S, since it believes that the bankruptcy of its subsidiary, will not have any material effect, except for a potential claim of approximately $0.5 million from a supplier contract for which the parent company Advent Technologies Holdings, Inc. is the guarantor.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the projections do not include any cash outflows relating to commitments and contingencies as disclosed in Note 22 to the consolidated financial statements, since the Company believes that any cash outflows relating to these commitments will not materialize based on the Company’s plans to agree the termination of such contracts with its suppliers and a contingent loss as outcome of the pending arbitration it is not probable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Until such time as the Company generates sufficient revenue to fund its operations (if ever), the Company plans to finance its operations and repay its existing and future liabilities and other obligations through the sale of equity and/or debt securities and, to the extent available, short-term and long-term loans. As part of its plan, on July 30, 2024, the Company entered into a securities purchase agreement, (the “Purchase Agreement”), with an institutional investor (the “Investor”) pursuant to which, at the closing, defined as the filing date of the Company’s 10-K, the Company will issue to the Investor a senior promissory note in the principal amount of $1 million (the “Senior Note”), repayable within one year and bearing interest of 18%. The Investor has also committed to provide the Company with a one-year revolving line of credit for an aggregate maximum principal amount of $2 million, again bearing interest of 18% (the two debt transactions are referred to as the “Financing”). The $2 million financing is contingent upon the Company’s filing of a Registration Statement on Form S-1 with the Securities and Exchange Commission with respect to an underwritten or “best efforts” public offering by the Company of its common stock, and/or common stock equivalents registered under the Securities Act of 1933, as amended for proceeds to the Company of not less than $5 million (a “Qualified Public Equity Offering”). The Company can give no assurances as of the date of issuance of the consolidated financial statements as to whether the Company will be successful in raising this Financing and executing a Qualified Public Equity Offering. The Company will use the proceeds from the Financing for general corporate purposes, including expenses related to the preparation of its Annual Report on Form 10-K for the year ended December 31, 2023, and expenses to facilitate a Qualified Public Equity Offering and the proceeds of the Qualified Public Equity Offering for general corporate purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With regards to the projected revenues and grants, a delay in the projected timing of inflows may result in the Company remaining insolvent and short of cash at any specific time over the next twelve months. Also, there is no guarantee that the Company’s plans to reduce monthly expenditures will be successful. Beyond that, there is no guarantee about when the Registration Statement in Form S-1 will be filed and therefore the committed one-year revolving line of credit of maximum $2 million will be received. In addition, there is no guarantee with regards to the Company’s ability to secure proceeds of not less than $5 million from the Qualified Public Entity Offering.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Company is unable to obtain sufficient funding, it could be required to delay its development efforts, limit activities, and further reduce research and development costs, which could adversely affect its business prospects and delivery of contractual obligations. A cash shortfall at any point in time over the next twelve months could result in the Company failing to meet its overdue and current obligations which could trigger action against the Company and/or its subsidiaries for liquidation by employees, authorities, or creditors. Because of the uncertainty in securing additional funding, delays in growth of revenue, failure to materialize cost-cutting efforts and the insufficient amount of cash and cash equivalents as of the consolidated financial statement filing date, management has concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern for one year from the date the consolidated financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32115000 usd
CY2023Q4 adn Negative Net Working Capital
NegativeNetWorkingCapital
3100000 usd
CY2023Q4 adn Ownership Percentage In Subsdaries
OwnershipPercentageInSubsdaries
1 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zXQkP3VDzDAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_864_zYHJdQ2FKkm9">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. On an on-going basis, management evaluates the estimates and judgments, including those related to the selection of useful lives for tangible assets, expected future cash flows from long-lived assets to support impairment tests, the carrying value of goodwill, provisions necessary for accounts receivables and inventory write downs, provisions for legal disputes, and contingencies. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates under different assumptions and/or conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
900000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
800000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3562000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32869000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
750000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4412000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33619000 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3600000 usd
CY2022Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
3600000 usd
CY2023 adn Period Of Warranty On Fuel Cells
PeriodOfWarrantyOnFuelCells
P2Y
CY2023 adn Percentage Of Accrue Warranty Reserve
PercentageOfAccrueWarrantyReserve
0.08 pure
CY2023 adn Period Of Warranty Reserve Expected To Be Incurred
PeriodOfWarrantyReserveExpectedToBeIncurred
P12M
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1047000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1048000 usd
CY2023 adn Additions
Additions
114000 usd
CY2022 adn Additions
Additions
460000 usd
CY2023 adn Settlements
Settlements
-274000 usd
CY2022 adn Settlements
Settlements
-401000 usd
CY2023 adn Foreign Exchange Fluctuations
ForeignExchangeFluctuations
24000 usd
CY2022 adn Foreign Exchange Fluctuations
ForeignExchangeFluctuations
-60000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
911000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1047000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
21000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
52000 usd
CY2023 adn Credit Loss
CreditLoss
900000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2015000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1019000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
CY2023 adn Income From Grants
IncomeFromGrants
2500000 usd
CY2022 adn Income From Grants
IncomeFromGrants
1500000 usd
CY2023Q4 adn Receivables From Grant Income
ReceivablesFromGrantIncome
600000 usd
CY2022Q4 adn Receivables From Grant Income
ReceivablesFromGrantIncome
300000 usd
CY2023Q4 us-gaap Deferred Income
DeferredIncome
900000 usd
CY2022Q4 us-gaap Deferred Income
DeferredIncome
900000 usd
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
100000 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
500000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
719000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1970000 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
26000 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
13000 usd
CY2023 us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<p id="xdx_840_eus-gaap--DerivativesMethodsOfAccountingNonhedgingDerivatives_z7jae5wXvEmj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_862_zIyIKsKb8P8f">Warrant Liability</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the Business Combination, the Company assumed a warrant liability (the “Warrant Liability”) related to previously issued <span id="xdx_90F_ecustom--ClassOfWarrantOrRightIssued_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pdd" title="Warrants issued (in shares)">131,343</span> warrants, each exercisable to purchase one <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" style="display: none" title="Number of shares called by each warrant (in shares)">1</span> share of common stock at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Exercise price (in dollars per share)">345.00</span> per share, originally sold to AMCI Sponsor LLC (the “Sponsor”) in a private placement consummated in connection with AMCI’s initial public offering (the “Private Placement Warrants”) and the <span id="xdx_90A_ecustom--ClassOfWarrantOrRightIssued_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember_pdd" title="Warrants issued (in shares)">13,333</span> warrants, each exercisable to purchase one <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" style="display: none" title="Number of shares called by each warrant (in shares)">1</span> share of common stock at an exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--WorkingCapitalWarrantsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Exercise price (in dollars per share)">345.00</span> per share, converted from the Sponsor’s non-interest bearing loan to the Company of $<span id="xdx_903_ecustom--NonInterestBearingLoan_pn3n3_dm_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zstx50k7yBU2" title="Non-interest bearing loan">0.4</span> million in connection with the closing of the Business Combination (the “Working Capital Warrants”) (Note 14). The Private Placement Warrants and the Working Capital Warrants have substantially the same terms as the <span id="xdx_90D_ecustom--ClassOfWarrantOrRightIssued_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember_pdd" title="Warrants issued (in shares)">734,309</span> warrants, each exercisable to purchase one share of common stock at an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivatePlacementWarrantMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Exercise price (in dollars per share)">345.00</span> per share, issued by AMCI in its initial public offering (the “Public Warrants”). As of December 31, 2023, the Company had an aggregate of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231_zw8kizPkgNs" title="Warrants outstanding">65,671</span> Private Placement Warrants and Working Capital Warrants outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables summarize the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 and December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_pn3n3_zD2vp1QSz4M4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 2)"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> <span id="xdx_8BC_zRWFZURNWmnj" style="display: none">Schedule of liabilities measured at fair value on recurring basis</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As of<br/> December 31,<br/> 2023</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">(Amounts in thousands)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Fair Value</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Unobservable Inputs<br/> (Level 3)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Assets</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 1pt">Available for sale financial asset</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrzCz4DUs0tj" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right" title="Assets">0</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zmYkBDMBGF14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right" title="Assets">0</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zB6NU4Hc3gEg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Assets">0</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_988_eus-gaap--AssetsFairValueDisclosure_iI_pn3n3_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zrlam067DEIj" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Assets">0</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Liabilities</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Warrant liability</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td> <td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20231231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Liabilities">59</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td> <td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Liabilities">59</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Liabilities">59</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_c20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Liabilities">59</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As of<br/> December 31,<br/> 2022</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">(Amounts in thousands)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Fair Value</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Unobservable Inputs<br/> (Level 3)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Assets</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 1pt">Available for sale financial asset</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td id="xdx_982_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right" title="Assets">320</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; width: 9%; text-align: right" title="Assets">320</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Assets">320</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Assets">320</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Liabilities</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Warrant liability</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td> <td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_c20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Liabilities">998</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td> <td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Liabilities">998</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_c20221231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Liabilities">998</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Liabilities">998</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8A5_ztFtfxHuyCz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of the Company’s remaining financial instruments reflected on the consolidated balance sheets and which consist of cash and cash equivalents, accounts receivables, net, other current assets, trade and other payables, and other current liabilities, approximate their respective fair values due to their short-term nature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in the fair value of Level 3 assets and liabilities for the years ended December 31, 2023 and 2022 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_pn3n3_zn3lEVipXHee" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 3)"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B9_zgaWKVO1WSzb" style="display: none">Schedule of change in fair value of warrant liability</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="8" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Available for Sale Financial Asset</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">(Amounts in thousands)</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the<br/> Year Ended<br/> December 31,<br/> 2023</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the<br/> Year Ended<br/> December 31,<br/> 2022</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; font-weight: bold; text-align: left">Estimated fair value (beginning of period)</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left">$</td> <td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zXDNYg2KVFbb" style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">320</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left">$</td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pn3n3_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z968oRn2ytQ8" style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1044">-</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Estimated fair value of available for sale financial asset acquired</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Estimated fair value of available for sale financial asset acquired"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Estimated fair value of available for sale financial asset acquired">311</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign exchange fluctuations</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_983_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Foreign exchange fluctuations"><span style="-sec-ix-hidden: xdx2ixbrl1050">-</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_981_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetForeignExchangeFluctuations_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Foreign exchange fluctuations">9</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Change in estimated fair value</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">(320</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value"><span style="-sec-ix-hidden: xdx2ixbrl1056">-</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Estimated fair value (end of period)</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zbW8NlD1c11j" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">0</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_pn3n3_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zcQtMuk8k3Kl" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">320</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="8" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Warrant Liability</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">(Amounts in thousands)</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the<br/> Year Ended<br/> December 31,<br/> 2023</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the<br/> Year Ended<br/> December 31,<br/> 2022</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 76%; font-weight: bold; text-align: left">Estimated fair value (beginning of period)</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left">$</td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z0LiJHrbDxh3" style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">998</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left">$</td> <td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z7zcli2BXbF8" style="font-family: Times New Roman, Times, Serif; width: 9%; font-weight: bold; text-align: right" title="Estimated fair value at beginning balance">10,373</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Estimated fair value of warrant issuance</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Estimated fair value of warrant issuance"><span style="-sec-ix-hidden: xdx2ixbrl1066">-</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Estimated fair value of warrant issuance"><span style="-sec-ix-hidden: xdx2ixbrl1068">-</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Change in estimated fair value</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">(394</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Change in estimated fair value">(9,375</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Reclassification of private placement warrants</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_984_ecustom--ReclassificationOfPrivatePlacementWarrants_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Reclassification of private placement warrants">(545</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_982_ecustom--ReclassificationOfPrivatePlacementWarrants_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Reclassification of private placement warrants"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Estimated fair value (end of period)</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zPyV8FXokCGc" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">59</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_c20220101__20221231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zcJO8vaQyM4c" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Estimated fair value at ending balance">998</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zyeIDPx3zVtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Warrant Liability is remeasured to its fair value at each reporting period and upon settlement. The change in fair value is recognized in “Fair value change of warrant liability” on the consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated fair value of the Private Placement Warrants and the Working Capital Warrants (each as defined below) is determined using Level 3 inputs by using the Black-Scholes model. The application of the Black-Scholes model requires the use of a number of inputs and significant assumptions including volatility. Significant judgment is required in determining the expected volatility of our common stock. Due to the limited history of trading of our common stock, we determined expected volatility based on a peer group of publicly traded companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following tables provide quantitative information regarding Level 3 fair value measurement inputs as of their measurement date December 31, 2023:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_pn3n3_zFVdtB1SwDyg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details 4)"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BA_zNPKSQAQPN32" style="display: none">Schedule of fair value measurements input</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="4" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Available for Sale Financial Asset</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Interest Rate</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_900_ecustom--FairValueOfAssetInterestRate_iI_pid_dp_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--MeasurementInputTypeAxis__custom--MeasurementInputInterestRateMember_zqzHu8ZV9foi" title="Interest Rate">8.00</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Discount Rate</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate_pid_dp_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zvADehini0x4" title="Discount Rate">8.00</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Remaining term (in years)</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--FinancialAssetRemainingTermInYears_dtY_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsAssetsMember_zl9eigHqqSr7" title="Remaining term (in years)">1.40</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="4" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Warrant Liability</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; width: 88%; text-align: left">Stock price</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_90B_eus-gaap--SharePrice_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pdd" title="Stock price">6.60</span></td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercise price (strike price)</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td> <td id="xdx_986_eus-gaap--OptionIndexedToIssuersEquityStrikePrice1_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_pdd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Exercise price (strike price)">345.00</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Risk-free interest rate</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z61WQUymAc92" title="Risk-free interest rate">4.12</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Volatility</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20230101__20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_zUM0pveRCFm9" title="Volatility">149.6</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Remaining term (in years)</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20231231__us-gaap--FairValueByLiabilityClassAxis__us-gaap--DerivativeFinancialInstrumentsLiabilitiesMember_z3fqb5sGuTYd" title="Remaining term (in years)">2.09</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zpdz9lJcRg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
65671 shares
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zE3skEDEnTy1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_862_zFzFsyrc5tD7">Concentration of Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><b><i>i)</i></b></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><b><i>Credit risk</i></b></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject us to a concentration of credit risk consist of cash, cash equivalents and accounts receivable. Our cash balances are primarily invested in money market funds or on deposits at high credit quality financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023 and 2022, the Company had two (<span id="xdx_90F_ecustom--NumberOfMajorCustomers_uCustomer_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zRufPKTGON2" title="Number of major customers"><span id="xdx_905_ecustom--NumberOfMajorCustomers_uCustomer_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zpL1mC1rIaE9" title="Number of major customers">2</span></span>) major customers that represented more than 10% of our accounts receivable balance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2023, the Company had three <span id="xdx_905_ecustom--NumberOfMajorCustomers_uCustomer_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z6Lifatb6zEa" style="display: none" title="Number of major customers">3</span> customers that represented more than 10% of its revenues. During the year ended December 31, 2022, the Company had three (<span id="xdx_908_ecustom--NumberOfMajorCustomers_uCustomer_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zF8HIxotiC75" title="Number of major customers">2</span>) major customers that each represented more than 10% of its revenues, on an individual basis, and together represented approximately $<span id="xdx_903_eus-gaap--Revenues_pn3n3_dm_c20230101__20231231__srt--MajorCustomersAxis__custom--ThreeCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNdmCLsi1YZ4">3.3 </span>million or <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_c20230101__20231231__srt--MajorCustomersAxis__custom--ThreeCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zA0Ry7DDGdE8">42% </span>of its total revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"><b>ii)</b></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"><b><i>Supply risk</i></b></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company obtains a limited number of components and supplies included in its products from a small group of suppliers. During the year ended December 31, 2023, the Company had one supplier who accounted for more than 10% of its total purchases. During the year ended December 31, 2022, the Company had no supplier who accounted for more than 10% of its total purchases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023Q4 adn Outstanding Balances With Related Parties
OutstandingBalancesWithRelatedParties
0 usd
CY2022Q4 adn Outstanding Balances With Related Parties
OutstandingBalancesWithRelatedParties
0 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
552000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1295000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
361000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
316000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
191000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
979000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
316000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
411000 usd
CY2023 adn Additions To Other Assets Amounts
AdditionsToOtherAssetsAmounts
-119000 usd
CY2022 adn Additions To Other Assets Amounts
AdditionsToOtherAssetsAmounts
-247000 usd
CY2023 adn Income From Unused Provisions
IncomeFromUnusedProvisions
40000 usd
CY2022 adn Income From Unused Provisions
IncomeFromUnusedProvisions
316000 usd
CY2023 adn Utilized Provisions During Year
UtilizedProvisionsDuringYear
40000 usd
CY2023 adn Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations
AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations
-6000 usd
CY2022 adn Accounts Receivable Allowance For Credit Loss Foreign Exchange Fluctuations
AccountsReceivableAllowanceForCreditLossForeignExchangeFluctuations
26000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
361000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
316000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
9461000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
7518000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
223000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
547000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5275000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4787000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
14959000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
12852000 usd
CY2023Q4 adn Provision For Inventory
ProvisionForInventory
12252000 usd
CY2022Q4 adn Provision For Inventory
ProvisionForInventory
232000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2707000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
12620000 usd
CY2022Q4 adn Change In Provision For Slow Moving Inventory Balance At Beginning
ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning
-232000 usd
CY2021Q4 adn Change In Provision For Slow Moving Inventory Balance At Beginning
ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning
-48000 usd
CY2023 adn Provision For Slow Moving Inventory Additions
ProvisionForSlowMovingInventoryAdditions
-12212000 usd
CY2022 adn Provision For Slow Moving Inventory Additions
ProvisionForSlowMovingInventoryAdditions
-204000 usd
CY2023 adn Provision For Slow Moving Inventory Foreign Exchange Fluctuations
ProvisionForSlowMovingInventoryForeignExchangeFluctuations
192000 usd
CY2022 adn Provision For Slow Moving Inventory Foreign Exchange Fluctuations
ProvisionForSlowMovingInventoryForeignExchangeFluctuations
20000 usd
CY2023Q4 adn Change In Provision For Slow Moving Inventory Balance At Beginning
ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning
-12252000 usd
CY2022Q4 adn Change In Provision For Slow Moving Inventory Balance At Beginning
ChangeInProvisionForSlowMovingInventoryBalanceAtBeginning
-232000 usd
CY2023 adn Schedule Of Prepaid Expenses
ScheduleOfPrepaidExpenses
<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfPrepaidExpenses_pn3n3_zjji8vgQ11Sb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Prepaid expenses and other current assets (Details)"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; text-align: left"><span id="xdx_8B1_zWyQ6ee3oBJ3" style="display: none">Schedule of prepaid expenses</span></td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_49B_20231231_zX0vmma0pQRf" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td id="xdx_495_20221231_zwOIkuLMQLc2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">(Amounts in thousands)</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,<br/> 2023</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,<br/> 2022</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidInsurance_iI_pn3n3_maPECzS5u_zE4BQ9Pk9vp4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; width: 76%; text-align: left">Prepaid insurance expenses</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right">155</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td> <td style="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right">263</td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PrepaidResearch_iI_pn3n3_maPECzS5u_zkFj009ukJnh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; text-align: left">Prepaid research expenses</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">36</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">212</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--PrepaidRent_iI_pn3n3_maPECzS5u_zZRUr1LaMmv2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; text-align: left">Prepaid rent expenses</td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">32</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OtherPrepaidExpenseCurrent_iI_pn3n3_maPECzS5u_zI7Gaq2ttGRj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt">Other prepaid expenses</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right">958</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right">181</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PrepaidExpenseCurrent_iTI_pn3n3_mtPECzS5u_zQJhZdBYDuYa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-indent: -0.25in; padding-left: 0.25in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total</td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right">1,149</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right">688</td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
155000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
263000 usd
CY2023Q4 adn Prepaid Research
PrepaidResearch
36000 usd
CY2022Q4 adn Prepaid Research
PrepaidResearch
212000 usd
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
32000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
958000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
181000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1149000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
688000 usd
CY2023Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
273000 usd
CY2022Q4 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
530000 usd
CY2023Q4 adn Withholding Tax
WithholdingTax
20000 usd
CY2022Q4 adn Withholding Tax
WithholdingTax
839000 usd
CY2023Q4 us-gaap Grants Receivable
GrantsReceivable
570000 usd
CY2022Q4 us-gaap Grants Receivable
GrantsReceivable
265000 usd
CY2023Q4 adn Purchases Under Receipt
PurchasesUnderReceipt
1000 usd
CY2022Q4 adn Purchases Under Receipt
PurchasesUnderReceipt
83000 usd
CY2023Q4 adn Guarantees
Guarantees
9000 usd
CY2022Q4 adn Guarantees
Guarantees
38000 usd
CY2023Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
152000 usd
CY2022Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
524000 usd
CY2022Q4 adn Accrued Interest Income
AccruedInterestIncome
13000 usd
CY2023Q4 adn Accrued Sublease Income
AccruedSubleaseIncome
80000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1105000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2292000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5742000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
30030000 usd
CY2022Q4 adn Cumulative Impairment Goodwill
CumulativeImpairmentGoodwill
-24288000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5742000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
30030000 usd
CY2023Q4 adn Cumulative Impairment Goodwill
CumulativeImpairmentGoodwill
-30030000 usd
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
406000 usd
CY2023 adn Impairment Of Intangible Asset Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetIndefinitelivedExcludingGoodwill
-406000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24332000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4684000 usd
CY2023Q4 adn Cumulative Impairment
CumulativeImpairment
-19569000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
79000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
24738000 usd
CY2023Q4 adn Intangible Assets Gross Excluding Goodwill Accumulated Amortization
IntangibleAssetsGrossExcludingGoodwillAccumulatedAmortization
-4684000 usd
CY2023Q4 adn Cumulative Impairment On Intangible Assets
CumulativeImpairmentOnIntangibleAssets
-19975000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
79000 usd
CY2022 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
406000 usd
CY2022 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
406000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24332000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4042000 usd
CY2022Q4 adn Cumulative Impairment
CumulativeImpairment
-14634000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5656000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
24738000 usd
CY2022Q4 adn Intangible Assets Gross Excluding Goodwill Accumulated Amortization
IntangibleAssetsGrossExcludingGoodwillAccumulatedAmortization
-4042000 usd
CY2022Q4 adn Cumulative Impairment On Intangible Assets
CumulativeImpairmentOnIntangibleAssets
-14634000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6062000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33568000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25255000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9635000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7317000 usd
CY2023Q4 adn Less Cumulative Impairment
LessCumulativeImpairment
-2384000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21549000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17938000 usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
9100000 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
10400000 usd
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
750000 usd
CY2023 us-gaap Property Plant And Equipment Cost Capitalization
PropertyPlantAndEquipmentCostCapitalization
Company had $10.4 million of leasehold improvements and $0.5 million of furniture that will be forfeited as part of the exit of Hood Park.
CY2023 adn Coating Machines Description
CoatingMachinesDescription
Company entered into an agreement to sell some of its coating machines (part of its property, plant and equipment) from the Hood Park facility for $0.9 million resulting in a loss of $2.4 million. On May 8, 2024, the Company received an initial deposit of $0.3 million and the remaining $0.6 million in July 2024.
CY2023 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
11500000 usd
CY2023 us-gaap Depreciation
Depreciation
3005000 usd
CY2022 us-gaap Depreciation
Depreciation
1493000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
831000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1522000 usd
CY2023Q4 adn Other Short Term Payables Current
OtherShortTermPayablesCurrent
262000 usd
CY2022Q4 adn Other Short Term Payables Current
OtherShortTermPayablesCurrent
2260000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
257000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
285000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
248000 usd
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
300000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
228000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
213000 usd
CY2023Q4 adn Other Current Liabilities Social Security Funds
OtherCurrentLiabilitiesSocialSecurityFunds
81000 usd
CY2022Q4 adn Other Current Liabilities Social Security Funds
OtherCurrentLiabilitiesSocialSecurityFunds
88000 usd
CY2023Q4 adn Other Current Liabilities Overtime Provision
OtherCurrentLiabilitiesOvertimeProvision
9000 usd
CY2022Q4 adn Other Current Liabilities Overtime Provision
OtherCurrentLiabilitiesOvertimeProvision
35000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1916000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4703000 usd
CY2022Q4 adn Accrued Construction Fees Current
AccruedConstructionFeesCurrent
476000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
219000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
159000 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
139000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
142000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
473000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
745000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
831000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1522000 usd
CY2022Q4 adn Business Combination Consideration Payable Cash
BusinessCombinationConsiderationPayableCash
2000000.0 usd
CY2021Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
6041
CY2021Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
500000 usd
CY2021Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
6041
CY2023Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
600000 usd
CY2023 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
543000 usd
CY2021Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
21401
CY2021Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
1500000 usd
CY2021Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P8Y6M
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q1 us-gaap Security Deposit
SecurityDeposit
800000 usd
CY2021Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
1017
CY2023 adn Rental Expense
RentalExpense
1800000 usd
CY2022 adn Rental Expense
RentalExpense
1600000 usd
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3216000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4055000 usd
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
2139000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1605000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y14D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.072 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2258000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2247000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1885000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1705000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1751000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3184000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13030000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2614000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10416000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2186000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8230000 usd
CY2023Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
83000 usd
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
72000 usd
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
72000 usd
CY2021Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
90000 usd
CY2023 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2000 usd
CY2022 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000 usd
CY2023 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
22000 usd
CY2022 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
26000 usd
CY2023 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
15000 usd
CY2022 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
40000 usd
CY2023 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
-2000 usd
CY2022 us-gaap Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation
DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
5000 usd
CY2023Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
83000 usd
CY2022Q4 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
72000 usd
CY2023 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2000 usd
CY2022 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1000 usd
CY2023 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
22000 usd
CY2022 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
26000 usd
CY2023 adn Total
Total
24000 usd
CY2022 adn Total
Total
27000 usd
CY2023 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
15000 usd
CY2022 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
40000 usd
CY2023 adn Actuarial Gains Losses
ActuarialGainsLosses
15000 usd
CY2022 adn Actuarial Gains Losses
ActuarialGainsLosses
40000 usd
CY2023Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0308 pure
CY2022Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
0.0290 pure
CY2023Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
0.0240 pure
CY2022Q4 us-gaap Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
0.0240 pure
CY2023Q4 adn Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Inflation
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationInflation
0.0210 pure
CY2022Q4 adn Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Inflation
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationInflation
0.0220 pure
CY2023 adn Defined Benefit Plan Demographic Assumptions Mortality
DefinedBenefitPlanDemographicAssumptionsMortality
EVK 2000 (male and female)
CY2023 adn Defined Benefit Plan Demographic Assumptions Disability
DefinedBenefitPlanDemographicAssumptionsDisability
50% EVK 2000
CY2023 adn Defined Benefit Plan Demographic Assumptions Retirement Age Limits
DefinedBenefitPlanDemographicAssumptionsRetirementAgeLimits
As defined by the Greek main insurance institution for each employee.
CY2023 adn Defined Benefit Plan Demographic Assumptions Turnover
DefinedBenefitPlanDemographicAssumptionsTurnover
0.0000 pure
CY2022Q4 adn Defined Benefit Obligation Changes In Principal Assumptions On Discount Rate
DefinedBenefitObligationChangesInPrincipalAssumptionsOnDiscountRate
0.0050 pure
CY2022Q4 adn Defined Benefit Obligation Increase In Principal Assumptions On Discount Rate
DefinedBenefitObligationIncreaseInPrincipalAssumptionsOnDiscountRate
-0.09 pure
CY2022Q4 adn Defined Benefit Obligation Decrease In Principal Assumptions On Discount Rate
DefinedBenefitObligationDecreaseInPrincipalAssumptionsOnDiscountRate
0.10 pure
CY2022Q4 adn Defined Benefit Obligation Changes In Principal Assumptions On Annual Salary Increase
DefinedBenefitObligationChangesInPrincipalAssumptionsOnAnnualSalaryIncrease
0.0050 pure
CY2022Q4 adn Defined Benefit Obligation Increase In Principal Assumptions On Annual Salary Increase
DefinedBenefitObligationIncreaseInPrincipalAssumptionsOnAnnualSalaryIncrease
0.06 pure
CY2022Q4 adn Defined Benefit Obligation Decrease In Principal Assumptions On Annual Salary Increase
DefinedBenefitObligationDecreaseInPrincipalAssumptionsOnAnnualSalaryIncrease
-0.08 pure
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
700000 usd
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
800000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
900000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1000000.0 usd
CY2023Q4 adn Percentage Of Accrued Warranty Reserve On Sale Price Of Goods Sold
PercentageOfAccruedWarrantyReserveOnSalePriceOfGoodsSold
0.08 pure
CY2023 adn Period Of Accrued Warranty Reserve
PeriodOfAccruedWarrantyReserve
P2Y
CY2023Q4 adn Number Of Shares Authorized
NumberOfSharesAuthorized
501000000 shares
CY2023Q4 adn Common Stock Shares Designated
CommonStockSharesDesignated
500000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2580159 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2580159 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1723924 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1723924 shares
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4859000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7837000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4859000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7837000 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
21000 usd
CY2022Q4 us-gaap Contract With Customer Asset Gross Current
ContractWithCustomerAssetGrossCurrent
52000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2000000.0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1000000.0 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 usd
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-35233000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18198000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-35445000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-58109000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70678000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76307000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-52000 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-52000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-30000 usd
CY2023 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-30000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
801000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-728000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1242000 usd
CY2023 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
801000 usd
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-1970000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
719000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1970000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14842000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16024000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1133000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-946000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
20443000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10255000 usd
CY2023 adn Income Tax Reconciliation Warranty Liability Income Taxes
IncomeTaxReconciliationWarrantyLiabilityIncomeTaxes
-83000 usd
CY2022 adn Income Tax Reconciliation Warranty Liability Income Taxes
IncomeTaxReconciliationWarrantyLiabilityIncomeTaxes
-1969000 usd
CY2023 adn Effect Of Nonus Income Tax Rates
EffectOfNonusIncomeTaxRates
-6801000 usd
CY2022 adn Effect Of Nonus Income Tax Rates
EffectOfNonusIncomeTaxRates
-3402000 usd
CY2023 adn Impairment
Impairment
1718000 usd
CY2022 adn Impairment
Impairment
6904000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1677000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
2159000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-260000 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1053000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
719000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1970000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36443000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
20186000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1128000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
13000 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1423000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1199000 usd
CY2023Q4 adn Lease Liability
LeaseLiability
2524000 usd
CY2022Q4 adn Lease Liability
LeaseLiability
3306000 usd
CY2023Q4 adn Sec174 Cap
Sec174Cap
1823000 usd
CY2022Q4 adn Sec174 Cap
Sec174Cap
887000 usd
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1073000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1255000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
295000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
45669000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25886000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42458000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21998000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3211000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3888000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
300000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
199000 usd
CY2023Q4 adn Lease Roa
LeaseRoa
2911000 usd
CY2022Q4 adn Lease Roa
LeaseRoa
3268000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
383000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
38000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3211000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3888000 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
20500000 usd
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4859000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7837000 usd
CY2023Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0 usd
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0 usd
CY2022Q4 adn Contractual Obligation Minimum Quantity
ContractualObligationMinimumQuantity
21000 sqm
CY2023Q4 adn Contractual Obligation Minimum Quantity Pieces
ContractualObligationMinimumQuantityPieces
3236 electrodes
CY2022Q3 adn Contractual Obligation Minimum Quantity Pieces
ContractualObligationMinimumQuantityPieces
318400
CY2023Q2 adn Contractual Obligation Minimum Quantity Pieces
ContractualObligationMinimumQuantityPieces
75400
CY2023Q4 adn Contractual Obligation Quantity Pieces Year One
ContractualObligationQuantityPiecesYearOne
57600
CY2023Q4 adn Contractual Obligation Quantity Year One
ContractualObligationQuantityYearOne
6174 sqm
CY2023Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
2235000 usd
CY2023Q4 adn Contractual Obligation Quantity Year Two
ContractualObligationQuantityYearTwo
8000 sqm
CY2023Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
2000000 usd
CY2023Q4 adn Contractual Obligation Quantity Pieces
ContractualObligationQuantityPieces
57600
CY2023Q4 adn Contractual Obligation Quantity
ContractualObligationQuantity
14174 sqm
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
4235000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-71397000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74337000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1917179 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1717623 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1917179 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1717623 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-37.24
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-43.28
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-37.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-43.28
CY2024Q2 us-gaap Line Of Credit
LineOfCredit
750000 usd
CY2024Q2 adn Sell Of Property Plant And Equipment Description
SellOfPropertyPlantAndEquipmentDescription
Company entered into an agreement to sell some of its coating machines (part of its property, plant and equipment) from the Hood Park facility for $0.9 million resulting in a loss of $2.4 million. On May 8, 2024, the Company received an initial deposit of $0.3 million and the remaining $0.6 million in July 2024.
CY2023Q4 adn Cash And Cash Equivalents
CashAndCashEquivalents
3562000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 adn Account Receivable Net
AccountReceivableNet
191000 usd
CY2023Q4 adn Contract Assets
ContractAssets
21000 usd
CY2023Q4 adn Inventories
Inventories
2707000 usd
CY2023Q4 adn Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
2254000 usd
CY2023Q4 adn Total Current Assets
TotalCurrentAssets
8835000 usd
CY2023Q4 adn Intangibles Net
IntangiblesNet
79000 usd
CY2023Q4 adn Property And Equipment Net
PropertyAndEquipmentNet
21549000 usd
CY2023Q4 adn Rightofuse Assets
RightofuseAssets
3216000 usd
CY2023Q4 adn Restricted Cash Noncurrents
RestrictedCashNoncurrents
750000 usd
CY2023Q4 adn Other Noncurrent Assets
OtherNoncurrentAssets
308000 usd
CY2023Q4 adn Total Noncurrent Assets
TotalNoncurrentAssets
25902000 usd
CY2023Q4 adn Total Assets
TotalAssets
34737000 usd
CY2023Q4 adn Trade And Other Payables
TradeAndOtherPayables
5087000 usd
CY2023Q4 adn Deferred Income From Grants Current
DeferredIncomeFromGrantsCurrent
530000 usd
CY2023Q4 adn Contract Liabilities
ContractLiabilities
2015000 usd
CY2023Q4 adn Other Current Liabilities
OtherCurrentLiabilities
1916000 usd
CY2023Q4 adn Operating Lease Liabilities
OperatingLeaseLiabilities
2186000 usd
CY2023Q4 adn Income Tax Payable
IncomeTaxPayable
179000 usd
CY2023Q4 adn Total Current Liabilities
TotalCurrentLiabilities
11913000 usd
CY2023Q4 adn Warrant Liability
WarrantLiability
59000 usd
CY2023Q4 adn Longterm Operating Lease Liabilities
LongtermOperatingLeaseLiabilities
8230000 usd
CY2023Q4 adn Defined Benefit Obligation
DefinedBenefitObligation
83000 usd
CY2023Q4 adn Deferred Income From Grants Noncurrent
DeferredIncomeFromGrantsNoncurrent
320000 usd
CY2023Q4 adn Other Longterm Liabilities
OtherLongtermLiabilities
684000 usd
CY2023Q4 adn Total Noncurrent Liabilities
TotalNoncurrentLiabilities
9376000 usd
CY2023Q4 adn Total Liabilities
TotalLiabilities
21289000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
194933000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2334000 usd
CY2023Q4 adn Accumulated Deficit
AccumulatedDeficit
-179159000 usd
CY2023Q4 adn Total Stockholders Equity
TotalStockholdersEquity
13448000 usd
CY2023Q4 adn Total Liabilities And Stockholders Equity
TotalLiabilitiesAndStockholdersEquity
34737000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1506000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1264000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1112000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
977000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12442000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2456000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1905000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1484000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
-10936000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-1192000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-793000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-507000 usd
CY2023Q4 adn Income From Grants
IncomeFromGrants
814000 usd
CY2023Q3 adn Income From Grants
IncomeFromGrants
496000 usd
CY2023Q2 adn Income From Grants
IncomeFromGrants
660000 usd
CY2023Q1 adn Income From Grants
IncomeFromGrants
534000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3957000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2131000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2883000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3141000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6732000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8916000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8331000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8489000 usd
CY2023Q4 us-gaap Sublease Income
SubleaseIncome
139000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
139000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
138000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
127000 usd
CY2023Q4 adn Amortization Of Intangibles
AmortizationOfIntangibles
-116000 usd
CY2023Q3 adn Amortization Of Intangibles
AmortizationOfIntangibles
-117000 usd
CY2023Q2 adn Amortization Of Intangibles
AmortizationOfIntangibles
-188000 usd
CY2023Q1 adn Amortization Of Intangibles
AmortizationOfIntangibles
-221000 usd
CY2023Q4 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
-1207000 usd
CY2023Q3 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
64000 usd
CY2023Q2 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
-127000 usd
CY2023Q4 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
-3705000 usd
CY2023Q2 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
-9763000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25700000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11657000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21287000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11697000 usd
CY2023Q4 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
39000 usd
CY2023Q3 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
-134000 usd
CY2023Q2 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
99000 usd
CY2023Q1 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
390000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-44000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
110000 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-12000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
159000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-41000 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-806000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25733000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11926000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21827000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11192000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-80000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
796000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-25732000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-11846000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-21831000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11988000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.04
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.89
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.26
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.92
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2136840 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2012382 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1780574 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1733439 shares
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.89
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.26
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.92
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2136840 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2012382 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1780574 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1733439 shares
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1957000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2399000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2225000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1256000 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2455000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2339000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2270000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
-498000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
60000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-45000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
-261000 usd
CY2022Q4 adn Income From Grants
IncomeFromGrants
449000 usd
CY2022Q3 adn Income From Grants
IncomeFromGrants
294000 usd
CY2022Q2 adn Income From Grants
IncomeFromGrants
209000 usd
CY2022Q1 adn Income From Grants
IncomeFromGrants
508000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2458000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2547000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2642000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2149000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9258000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8203000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7956000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10498000 usd
CY2022Q4 adn Amortization Of Intangibles
AmortizationOfIntangibles
-651000 usd
CY2022Q3 adn Amortization Of Intangibles
AmortizationOfIntangibles
-696000 usd
CY2022Q2 adn Amortization Of Intangibles
AmortizationOfIntangibles
-718000 usd
CY2022Q1 adn Amortization Of Intangibles
AmortizationOfIntangibles
-699000 usd
CY2022Q4 adn Credit Loss Customer Contracts
CreditLossCustomerContracts
-1116000 usd
CY2022Q4 adn Gain From Purchase Price Adjustment
GainFromPurchasePriceAdjustment
2370000 usd
CY2022Q4 adn Impairment Loss Intangible Assets And Goodwill
ImpairmentLossIntangibleAssetsAndGoodwill
-38922000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-50084000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11092000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11152000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13099000 usd
CY2022Q4 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
2127000 usd
CY2022Q3 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
-911000 usd
CY2022Q2 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
-217000 usd
CY2022Q1 adn Fair Value Change Of Warrant Liability
FairValueChangeOfWarrantLiability
8376000 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
61000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10000 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-40000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-33000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-17000 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-218000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47932000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12035000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11587000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4753000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-307000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-567000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-439000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-657000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-47625000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-11468000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11148000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4096000 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-27.63
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.66
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.50
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.40
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1723924 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1722004 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1715894 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1708453 shares
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-27.63
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.66
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.50
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.40
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1723924 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1722004 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1715894 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1708453 shares

Files In Submission

Name View Source Status
adn-20231231_cal.xml Edgar Link unprocessable
0001829126-24-005453-index-headers.html Edgar Link pending
0001829126-24-005453-index.html Edgar Link pending
0001829126-24-005453.txt Edgar Link pending
0001829126-24-005453-xbrl.zip Edgar Link pending
adn-20231231.xsd Edgar Link pending
adventtech_10k.htm Edgar Link pending
adventtech_ex21-1.htm Edgar Link pending
adventtech_ex23-1.htm Edgar Link pending
adventtech_ex31-1.htm Edgar Link pending
adventtech_ex31-2.htm Edgar Link pending
adventtech_ex32-1.htm Edgar Link pending
adventtech_ex32-2.htm Edgar Link pending
adventtech_ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img_001.jpg Edgar Link pending
img_002.jpg Edgar Link pending
img_003.jpg Edgar Link pending
img_004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
adn-20231231_pre.xml Edgar Link unprocessable
adn-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
adn-20231231_def.xml Edgar Link unprocessable
adventtech_10k_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending